L. Howard (London, United Kingdom), A. Reis (Porto, Portugal)
The effects of multiple dosing of ketoconazole on the pharmacokinetics of a single dose ambrisentan
D. Richards, G. Walker, A. Mandagere, M. Magee, L. Henderson, S. Harris (Harlow, Essex, United Kingdom; Westminster, CO, Philadelphia, Miami, United States Of America)
|  |
The role of nitric oxide in pathogenesis of high altitude pulmonary hypertension
B. Kojonazarov, A. Maripov, M. Kochkorova, T. Sooronbaev, M. Mirrakhimov, N. Morrell, M. Wilkins, A. Aldashev (Bishkek, Kyrgyzstan; Cambridge, London, United Kingdom)
|  |
Evaluation of right ventricular function by tissue doppler imaging in highlanders
A. Maripov, B. Kojonazarov, A. Sarybaev, A. Aldashev (Bishkek, Kyrgyzstan)
| |
Pulmonary veno-occlusive disease: clinical, functional, radiologic and hemodynamic characteristics and outcome of 24 cases confirmed by histology
D. Montani, L. Achouh, P. Dorfmüller, A. Rabiller, R. Haque, O. Sitbon, X. Jaïs, P. Dartevelle, G. Simonneau, M. Humbert (Clamart, Le Plessis-Robinson, France)
| |
Hemodynamic response to supplemental oxygen in chronic pulmonary hypertension
H. Leuchte, C. Baezner, R. Baumgartner, P. Mernitz, C. Neurohr, J. Behr (Munich, Germany)
| |
Nocturnal desaturations are common in portopulmonary hypertension
M. Halank, S. Langner, M. Kolditz, S. Miehlke, G. Hoeffken (Dresden/Saxony, Germany)
| |
Use of a telemedicine application for training and follow up of patients with pulmonary arterial hypertension
C. Nickerson, K. Nikander (Parsippany, NJ, United States Of America)
| |
Gas exchange abnormalities are linked to a decrease of capillary blood volume in cirrhotic patients
B. Degano, J. Rami, C. Bureau, B. Suc, L. Rostaing (Clamart, Toulouse, France)
| |
Nitric oxide from alveolar origin in cirrhotic patients: relationship with pulmonary haemodynamics and potential implications
B. Degano, J. Rami, B. Suc, C. Bureau, L. Rostaing (Clamart, Toulouse, France)
| |
Baseline profile of patients initiating sitaxentan for pulmonary arterial hypertension (PAH): preliminary results from thelin outcomes for patients surveillance (TOPS)
P. Blin, K. Bouillon, L. Abenhaim, N. Galie (Paris, France; Bologna, Italy)
| |
Cystamine and sildenafil in treatment of right ventricular hypertrophy in rats with pulmonary hypertension
L. H. Markvardsen, J. D. Baandrup, M. Kruhoffer, U. Simonsen (Aarhus C, Aarhus N, Denmark)
| |
Acute effect of sildenafil (PDE-5) on cardiopulmonary interactions in patients with pulmonary arterial hypertension (PAH) secondary to pulmonary fibrosis
K. E. Lyskanowska, A. Pierini, L. Allegra, G. Milani, S. Aliberti, F. Blasi (Milan, Italy)
| |
Cardiopulmonary assessment in morbid obese related to metabolic syndrome
T. E. Orizaga Franco, J. E. Morales Blanhir, E. Garcia Garcia, M. D. J. Rosas Romero (Mexico City, Mexico)
| |
Pulmonary hypertension and obesity
O. Alexandrov, R. Alekhina, B. Kaganov, N. Ayrapetyan (Moscow, Russian Federation)
| |
Bedside prediction of pulmonary hypertension among cirrhotic patients with portal hypertension
W. Gadallah, S. Atta, L. Abdelbaki, M. Soliman (Assiut, Egypt)
| |
Retrospective review of patient logging system data from an adaptive aerosol delivery system used for the delivery of iloprost inhalation solution
K. Nikander, J. Denyer (Parsippany, NJ, United States Of America; Chichester, United Kingdom)
| |
Prevalence of pulmonary circulation abnormalities in liver transplantation candidates
M. Gazzana, A. John, S. Fagondes, S. Garcia, D. Spader, D. Rigotti, S. Menna Barreto (Porto Alegre – Rio Grande do Sul, Brazil)
| |
Dynamic hyperinflation during exercise in patients with pulmonary hypertension
F. Reichenberger, M. Richter, R. Voswinckel, H. Ghofrani, W. Seeger (Giessen, Germany)
| |
Causes of death in patients with chronic obstructive pulmonary disease, analysis of autopsy material
B. Zvezdin, S. Milutinov, S. Hromis, M. Kojicic, S. Gavrilovic (Sremska Kamenica, Serbia And Montenegro)
| |
Assessment of simvastatin treatment on pulmonary arterial hypertension
A. Mozafari (Qom City, Qom Provice, Islamic Republic Of Iran)
| |